According to the latest United Nations estimates, worldwide more than 40 million people are infected with HIV, and the prevalence levels for this virus will continue to rise globally. Historically, vaccines have proven to be the most effective weapon in our fight against infectious diseases such as smallpox, polio, measles, and yellow fever. HIV vaccines are our best hope to end the HIV pandemic.
To control the alarming spread of HIV, a vital need exists for developing an effictive vaccine that would prevent individuals from becoming infected.
In an effort to discover a preventive HIV vaccine, NIAID currently supports preclinical and clinical vaccine research and development.
A listing of resources, reagents, facilities, and databases to assist the progress of HIV vaccine research projects.
Funding opportunities for HIV vaccine research.
Upcoming and past meetings.
Reports of meetings on issues concerning HIV vaccine research; articles relevant to HIV vaccine research by NIAID staff.
Groups that advise NIH on scientific opportunities, gaps in current knowledge, and the future direction of AIDS vaccine research, or which coordinate NIH-supported vaccine activities.
HIV/AIDS news releases.
HIV vaccine clinical trials supported by NIAID and other federal and private organizations.